IPFS News Link • Healthcare Industry
-
Special Editions
- Global
- Due Diligence
- Love Bus Liberty Tour
- Vaccine Education Summit
- Bitcoin Summit
- US-Arizona
- US-Tennessee
- Ernie's Favorites
- THE R3VOLUTION CONTINUES
- "It's Not My Debt"
- Fascist Nation's Favorites
- Surviving the Greatest Depression
- The Only Solution - Direct Action Revolution
- Western Libertarian
- S.A.F.E. - Second Amendment is For Everyone
- Freedom Summit
- Declare Your Independence
- FreedomsPhoenix Speakers Bureau
- Wallet Voting
- Harhea Phoenix
- Black Market Friday
IPFS News Link • Healthcare Industry
From 2001 to 2006, the percentage of new products cut from development when drugs are first tested against placebo, rose by 20 per cent. Half of all drugs that fail in late-stage trials drop out because of their inability to beat sugar pills.
Last November, a new type of gene therapy for Parkinson's disease,
championed by the Michael J Fox Foundation, was abruptly withdrawn from
Phase II trials after unexpectedly tanking against placebo. A stem-cell
startup called Osiris Therapeutics got a drubbing on Wall Street in
March, when it suspended trials of its pill for Crohn's disease, an
intestinal ailment, citing an "unusually high" response to placebo. Two
days later, Eli Lilly broke off tests on a new schizophrenia drug when
volunteers showed double the expected level of placebo response.
Current News | Contents By Subject
Additional Related items you might find interesting:Related items:
News Link •
Healthcare Industry
America's Infant Mortality Rate Increases for the First Time in 20 Years
News Link •
Science, Medicine and Technology
Germ and Terrain Disease Theories are Covers for Killer Institutions
News Link •
Healthcare
Cancer Cured for All 12 patients who experienced complete rectal cancer remission...
News Link •
Healthcare Industry
CAR-T Cell Therapy Achieves Near-Complete Tumor Regression in Brain Cancer After Five Days
News Link •
Science, Medicine and Technology